Topiramate hyperpolarizes and modulates the slow poststimulus AHP of rat olfactory cortical neurones in vitro

British Journal of Pharmacology

Volumn 141, Issue 2, 2004, Pages 285-301

  Russo, Emilio ^a,b   Constanti, Andrew ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Acetazolamide; Benzolamide; Intracellular recording; Olfactory cortical brain slices; Topiramate; Voltage clamp

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; BICARBONATE; CALCIUM CHANNEL L TYPE; CALCIUM ION; CARBONATE DEHYDRATASE INHIBITOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; NIFEDIPINE; POTASSIUM ION; TOPIRAMATE;

AFTERHYPERPOLARIZATION; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; ION CONDUCTANCE; MEMBRANE CURRENT; NONHUMAN; OLFACTORY CORTEX; OLFACTORY NERVE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; VOLTAGE CLAMP;

EID: 1342280377     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705617     Document Type: Article

References (100)

1. ALREJA, M. & AGHAJANIAN, G.K. (1993). Opiates suppress a resting sodium-dependent inward current and activate an outward potassium current in locus coeruleus neurons. J. Neurosci., 13, 3525-3532.
2. ANGEHAGEN, M., BEN-MENACHEM, E., RONNBACK, L. & HANSSON, E. (2003). Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate. Neurochem. Res., 28, 333-340.
3. ANWYL, R. (1991). Modulation of vertebrate neuronal calcium channels by transmitters. Brain Res. Brain Res. Rev., 16, 265-281.
4. ASCONAPE, J.J. (2002). Some common issues in the use of antiepileptic drugs. Semin. Neurol., 22, 27-39.
5. BAUER, J. & SCHWALEN, S. (2000). Topiramate (Topamax). Pharmacological characteristics and current use in epilepsy treatment. Nervenarzt, 71, 495-501.
6. + channel expressed in brainstem respiratory neurons. Respir. Physiol., 129, 159-174.
7. BEAN, B.P. (1989). Classes of calcium channels in vertebrate cells. Annu. Rev. Physiol., 51, 367-384.
8. BELL, D.C., BUTCHER, A.J., BERROW, N.S., PAGE, K.M., BRUST, P.F., NESTEROVA, A., STAUDERMAN, K.A., SEABROOK, G.R., NURNBERG, B. & DOLPHIN, A.C. (2001). Biophysical properties, pharmacology, and modulation of human, neuronal L-type (alpha(1D),Ca(V)1.3) voltage-dependent calcium currents. J. Neurophysiol., 85, 816-827.
9. BERLANT, J. & VAN KAMMEN, D.P. (2002). Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J. Clin. Psychiatry, 63, 15-20.
10. BRODIE, M.J. (2001). Management strategies for refractory localization-related seizures. Epilepsia, 42, 27-30.
11. CASINI, A., ANTEL, J., ABBATE, F., SCOZZAFAVA, A., DAVID, S., WALDECK, H., SCHAFER, S. & SUPURAN, C.T. (2003). Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. Bioorg. Med. Chem. Lett., 13, 841-845.
12. CASINI, A., SCOZZAFAVA, A., MASTROLORENZO, A. & SUPURAN, L.T. (2002). Sulfonamides and sulfonylated derivatives as anticancer agents. Curr. Cancer Drug Targets, 2, 55-75.
13. 2+ channels and their role in neurotransmitter release. Cell Calcium, 24, 307-323.
14. CHURCH, J. & MCLENNAN, H. (1989). Electrophysiological properties of rat CA1 pyramidal neurones in vitro modified by changes in extracellular bicarbonate. J. Physiol., 415, 85-108.
15. 2- to HEPES-buffered medium modifies membrane properties of rat CA1 pyramidal neurones in vitro. J. Physiol., 455, 51-71.
16. CHURCH, J. (1999). Effects of pH changes on calcium-mediated potentials in rat hippocampal neurons in vitro. Neuroscience, 89, 731-742.
17. + channel in cultured rat hippocampal neurones. J. Physiol., 511, 119-132.
18. CONSTANTI, A. & SIM, J.A. (1987). Calcium-dependent potassium conductance in guinea-pig olfactory cortex neurones in vitro. J. Physiol., 387, 173-194.
19. CONSTANTI, A., BAGETTA, G. & LIBRI, V. (1993). Persistent muscarinic excitation in guinea-pig olfactory cortex neurons: involvement of a slow post-stimulus afterdepolarizing current. Neuroscience, 56, 887-904.
20. CONSTANTI, A., GALVAN, M., FRANZ, P. & SIM, J,A. (1985). Calcium-dependent inward currents in voltage-clamped guinea-pig olfactory cortex neurones. Pflügers Arch., 404, 259-265.
21. COPPOLA, G., CALIENDO, G., TERRACCIANO, M.M., BUONO, S., PELLEGRINO, L. & PASCOTTO, A. (2001). Topiramate in refractory partial-onset seizures in children, adolescents and young adults: a multicentric open trial. Epilepsy Res., 43, 255-260.
22. COPPOLA, G., CALIENDO, G., VEGGIOTTI, P., ROMEO, A., TORTORELLA, G., DE MARCO, P. & PASCOTTO, A. (2002). Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study. Epilepsy Res., 51, 147-153.
23. DE SARRO, G., ASCIOTI, C., DI PAOLA, E.D., VIDAL, M.J. & DE SARRO, A. (1992). Effects of antiepileptic drugs, calcium channel blockers and other compounds on seizures induced by activation of voltage-dependent L calcium channel in DBA/2 mice. Gen. Pharmacol., 23, 205-216.
24. DELORENZO, R.J., SOMBATI, S. & COULTER, D.A. (2000). Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia, 41 (Suppl 1), S40-S44.
25. DODGSON, S.J., SHANK, R.P. & MARYANOFF, B.E. (2000). Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia, 41 (Suppl 1), S35-S39.
26. DOLPHIN, A.C. (1999). L-type calcium channel modulation. Adv. Second Messenger Phosphoprotein Res., 33, 153-177.
27. 2+ exchanger, NCKX2. J. Biol. Chem., 276, 25919-25928.
28. EATON, D.C. & BRODWICK, M.S. (1980). Effects of barium on the potassium conductance of squid axon. J. Gen. Physiol., 75, 727-750.
29. GALVAN, M., CONSTANTI, A. & FRANZ, P. (1985). Calcium-dependent action potentials in guinea-pig olfactory cortex neurones. Pflügers Arch., 404, 252-258.
30. GIBBS III, J.W., SOMBATI, S., DELORENZO, R.J. & COULTER, D.A. (2000). Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia, 41 (Suppl 1), S10-S16.
31. GUSTAFSSON, B. & WIGSTRÖM, H. (1983). Hyperpolarization following long-lasting tetanic activation of hippocampal pyramidal cells. Brain Res., 275, 159-163.
32. HANAYA, R., SASA, M., UJIHARA, H., ISHIHARA, K., SERIKAWA, T., IIDA, K., AKIMITSU, T., ARITA, K. & KURISU, K. (1998). Suppression by topiramate of epileptiform burst discharges in hippocampal CA3 neurons of spontaneously epileptic rat in vitro. Brain Res., 789, 274-282.
33. HARVEY, J.A., SCHOLFIELD, C.N. & BROWN, D.A. (1974). Evoked surface-positive potentials in isolated mammalian olfactory cortex. Brain Res., 76, 235-245.
34. HERNANDEZ-LOPEZ, S., BARGAS, J., REYES, A. & GALARRAGA, E. (1996). Dopamine modulates the afterhyperpolarization in neostriatal neurones. Neuroreport, 7, 454-456.
35. HERRANZ, J.L. (2000). Topiramate: a broad spectrum antiepileptic administered to 224 patients with refractory epilepsies. Rev. Neurol., 31, 822-828.
36. HERRERO, A.I., DEL OLMO, N., GONZALEZ-ESCALADA, J.R. & SOLIS, J.M. (2002). Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance. Neuropharmacology, 42, 210-220.
37. ISHIMATSU, M. & WILLIAMS, J.T. (1996). Synchronous activity in locus coeruleus results from dendritic interactions in pericoerulear regions. J. Neurosci., 16, 5196-5204.
38. 2+ buffer. Neuroscience, 88, 719-726.
39. JAHROMI, S.S., PELLETIER, M.R., MCDONALD, P.J., KHOSRAVANI, H. & CARLEN, P.L. (2000). Antiepileptic efficacy of topiramate: assessment in two in vitro seizure models. Brain Res., 872, 20-28.
40. KANG, Y., OKADA, T. & OHMORI, H. (1998). A phenytoin-sensitive cationic current participates in generating the afterdepolarization and burst afterdischarge in rat neocortical pyramidal cells. Eur. J Neurosci., 10, 1363-1375.
41. KAWASAKI, H., TANCREDI, V., D'ARCANGELO, G. & AVOLI, M. (1998). Multiple actions of the novel anticonvulsant drug topiramate in the rat subiculum in vitro. Brain Res., 807, 125-134.
42. 2+ transients. Proc. Natl. Acad. Sci. U.S.A., 87, 4083-4087.
43. + channel with unique pore properties. Neuron, 20, 995-1005.
44. KWAN, P., SILLS, G.J. & BRODIE, M.J. (2001). The mechanisms of action of commonly used antiepileptic drugs. Pharmacol. Ther., 90, 21-34.
45. + currents in rat hippocampal neurones. J. Physiol., 522, 231-246.
46. LENIGER, T., WIEMANN, M., BINGMANN, D., WIDMAN, G., HUFNAGEL, A. & BONNET, U. (2002). Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons. Epilepsia, 43, 469-474.
47. LESAGE, F. (2003). Pharmacology of neuronal background potassium channels. Neuropharmacology, 44, 1-7.
48. LIBRI, V., CONSTANTI, A., CALAMINICI, M. & NISTICÓ, G. (1994). A comparison of the muscarinic response and morphological properties of identified cells in the guinea-pig olfactory cortex in vitro. Neuroscience, 59, 331-347.
49. LÖSCHER, W. & EBERT, U. (1996). The role of the piriform cortex in kindling. Prog. Neurobiol., 50, 427-481.
50. MAIN, M.J., CRYAN, J.E., DUPERE, J.R., COX, B., CLARE, J.J. & BURBIDGE, S.A. (2000). Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol. Pharmacol., 58, 253-262.
51. B receptor sensitivity in rat brain and spinal cord. Neuroreport, 6, 399-403.
52. MAREN, T.H. (1977). Use of inhibitors in physiological studies of carbonic anhydrase. Am. J. Physiol., 232, F291-F297.
53. + currents mediating the hypoglycemic hyperpolarization of rat midbrain dopaminergic neurones. Neuropharmacology, 39, 1021-1028.
54. MARYANOFF, B.E., NORTEY, S.O., GARDOCKI, J.F., SHANK, R.P. & DODGSON, S.P. (1987). Anticonvulsant O-alkyl sulfamates. 2,3:4,5-bis-O-(1- methylethylydiene)-β-D-fructopyranose sulfamate and related compounds. J. Med. Chem., 30, 880-887.
55. MARYANOFF, B.E., COSTANZO, M.J., NORTEY, S.O., GRECO, M.N., SHANK, R.P., SCHUPSKY, J.J., ORTEGON, M.P. & VAUGHT, J.L. (1998). Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives. J. Med. Chem., 41, 1315-1343.
56. MCELROY, S.L., ARNOLD, L.M., SHAPIRA, N.A., KECK P.E. JR, P.E., ROSENTHAL, N.R., KARIM, M.R., KAMIN, M. & HUDSON, J.I. (2003). Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am. J. Psychiatry, 160, 255-261.
57. MEIERKORD, H., GRUNIG, F., GUTSCHMIDT, U., GUTIERREZ, R., PFEIFFER, M., DRAGUHN, A., BRUCKNER, C. & HEINEMANN, U. (2000). Sodium bromide: effects on different patterns of epileptiform activity, extracellular pH changes and GABAergic inhibition. Naunyn-Schmiedeberg's Arch. Pharmacol., 361, 25-32.
58. MILLICHAP, J.G., WOODBURY, D.M. & GOODMAN, L.S. (1955). Mechanisms of the anticonvulsant action of acetazolamide, a carbonic anhydrase inhibitor. J. Pharmacol. Exp. Ther., 115, 251-258.
59. MIMURA, Y., GOTOW, T., NISHI, T. & OSAME, M. (1994). Mechanisms of hyperpolarization induced by two cytokines, hTNF alpha and hIL-1 alpha in neurons of the mollusc, Onchidium. Brain Res., 653, 112-118.
60. MUNSCH, T. & PAPE, H.C. (1999). Upregulation of the hyperpolarization-activated cation current in rat thalamic relay neurones by acetazolamide. J. Physiol., 519, 505-514.
61. NICOLL, R.A. (1988). The coupling of neurotransmitter receptors to ion channels in the brain. Science, 241, 545-551.
62. PANAYIOTOPOULOS, C.P. (2001). Treatment of typical absence seizures and related epileptic syndromes. Paediatr. Drugs, 3, 379-403.
63. + conductance contribute to a posttetanic hyperpolarization in lamprey sensory neurons. J. Neurophysiol., 76, 540-553.
64. PASCUAL, J. (1999). New prospects in the treatment of migraine. Neurologia, 14 (Suppl 6), 26-35.
65. PASTERNACK, M., VOIPIO, J. & KAILA, K. (1993). Intracellular carbonic anhydrase activity and its role in GABA-induced acidosis in isolated rat hippocampal pyramidal neurones. Acta Physiol. Scand., 148, 229-231.
66. + current underlying the slow spike frequency adaptation in hippocampal neurons. Neuron, 11, 1023-1035.
67. + current sIAHP by a phosphatase-kinase balance under basal conditions in rat CA1 pyramidal neurons. J. Neurophysiol., 79, 3252-3256.
68. PRIVITERA, M.D., BRODIE, M.J., MATTSON, R.H., CHADWICK, D.W., NETO, W. & WANG, S. (2003). Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol. Scand., 107, 165-175.
69. REIS, J., TERGAU, F., HAMER, H.M., MULLER, H.H., KNAKE, S., FRITSCH, B., OERTEL, W.H. & ROSENOW, F. (2002). Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia, 43, 1149-1156.
70. RESOR, S.R., RESOR, L.D., WOODBURY, D.M. & KEMP, J.W. (1995). Acetazolamide. In: Antiepileptic Drugs, ed. Levy, R.H., Mattson, R.H. & Meldrum, B.S., pp. 969-985, New York: Raven Press.
71. RUSSO, E. & CONSTANTI, A. (2002). Topiramate enhances and prolongs the slow post-stimulus afterhyperpolarization (sAHP) in rat olfactory cortical neurones in vitro. Br. J. Pharmacol., 135, 81.
72. RUSSO, E., WHALLEY, B. & CONSTANTI, A. (2003). Topiramate modulates L-type calcium currents in rat olfactory cortical neurones in vitro. Br. J. Pharmacol., 138, 188.
73. SAH, P. & FABER, E.S. (2002). Channels underlying neuronal calcium-activated potassium currents. Prog. Neurobiol., 66, 345-353.
74. SCHWINDT, P.C., SPAIN, W.J. & CRILL, W.E. (1992). Effects of intracellular calcium chelation on voltage-dependent and calcium-dependent currents in cat neocortical neurons. Neuroscience, 47, 571-578.
75. SCHWINDT, P.C., SPAIN, W.J., FOEHRING, R.C., CHUBB, M.C. & CRILL, W.E. (1988). Slow conductances in neurons from cat sensorimotor cortex in vitro and their role in slow excitability changes. J. Neurophysiol., 59, 450-467.
76. SHANK, R.P., GARDOCKI, J.F., STREETER, A.J. & MARYANOFF, B.E. (2000). An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia, 41 (Suppl 1), S3-S9.
77. SHANK, R.P., GARDOCKI, J.F., VAUGHT, J.L., DAVIS, C.B., SCHUPSKY, J.J., RAFFA, R.B., DODGSON, S.J., NORTEY, S.O. & MARYANOFF, B.E. (1994). Topiramate: preclinical evaluation of structurally novel anticonvulsant. Epilepsia, 35, 450-460.
78. SIMONDS, W.F. (1999). G protein regulation of adenylate cyclase. Trends Pharmacol Sci., 20, 66-73.
79. STRAUB, H., KOHLING, R., FRIELER, A., GRIGAT, M. & SPECKMANN, E.J. (2000). Contribution of L-type calcium channels to epileptiform activity in hippocampal and neocortical slices of guinea-pigs. Neuroscience, 95, 63-72.
80. SUPPES, T. (2002). Review of the use of topiramate for treatment of bipolar disorders. J. Clin. Psychopharmacol., 22, 599-609.
81. + current fractions by the new anticonvulsant topiramate. Pharmacol. Exp. Ther., 288, 960-968.
82. THOMPSON, S.M. & PRINCE, D.A. (1986). Activation of electrogenic sodium pump in hippocampal CA1 neurons following glutamate-induced depolarization. J. Neurophysiol., 56, 507-522.
83. 2+ currents in isolated rat CA1 neurons. J. Physiol., 493, 719-732.
84. 2+ currents in isolated rat CA1 neurons. J. Neurophysiol., 77, 639-653.
85. TONG, C.K., BRION, L.P., SUAREZ, C. & CHESLER, M. (2000). Interstitial carbonic anhydrase (CA) activity in brain is attributable to membrane-bound CA type IV. J. Neurosci., 20, 8247-8253.
86. TRAVAGLI, R.A., DUNWIDDIE, T.V. & WILLIAMS, J.T. (1995). Opioid inhibition in locus coeruleus. J. Neurophysiol., 74, 518-528.
87. 2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis. Ann. Neurol., 48, 304-312.
88. TROTIER, D. & DOVING, K.B. (1996). Direct influence of the sodium pump on the membrane potential of vomeronasal chemoreceptor neurones in frog. J. Physiol., 490, 611-621.
89. VELUMIAN, A.A. & CARLEN, P.L. (1999). Differential control of three after-hyperpolarizations in rat hippocampal neurones by intracellular calcium buffering. J. Physiol., 517, 201-216.
90. VORSTRUP, S., JENSEN, K.E., THOMSEN, C., HENRIKSEN, O., LASSEN, N.A. & PAULSON, O.B. (1989). Neuronal pH regulation: constant normal intracellular pH is maintained in brain during low extracellular pH induced by acetazolamide - 31P NMR study. J. Cereb. Blood Flow Metab., 9, 417-421.
91. WAGNER, P.G. & DEKIN, M.S. (1993). GABAb receptors are coupled to a barium-insensitive outward rectifying potassium conductance in premotor respiratory neurons. J. Neurophysiol., 69, 286-289.
92. WHITE, H.S., BROWN, S.D., WOODHEAD, J.H., SKEEN, G.A. & WOLF, H.H. (2000). Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia, 41 (Suppl 1), S17-S20.
93. WICKENDEN, A.D. (2002). Potassium channels as anti-epileptic drug targets. Neuropharmacology, 43, 1055-1060.
94. + current in rat subthalamic nucleus neurones. J. Physiol., 527, 493-506.
95. WOLF, C.E., CROOKS, C.R. & POKLIS, A. (2000). Rapid gas chromatographic procedure for the determination of topiramate in serum. J. Anal. Toxicol., 24, 661-663.
96. WU, S.P., TSAI, J.J. & GEAN, P.W. (1998). Frequency-dependent inhibition of neuronal activity by topiramate in rat hippocampal slices. Br. J. Pharmacol., 125, 826-832.
97. 2+ chelators in hippocampal CA1 neurons of rat brain slices. J. Neurophysiol., 74, 2225-2241.
98. ZHANG, X., VELUMIAN, A.A., JONES, O.T. & CARLEN, P.L. (2000). Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia, 41 (Suppl 1), S52-S60.
99. ZHU, G., CHANCHEVALAP, S., CUI, N. & JIANG, C. (1999). Effects of intra-and extracellular acidifications on single channel Kir2.3 currents. J. Physiol., 516, 699-710.
100. ZVARTAU-HIND, M., DIN, M.U., GILANI, A., LISAK, R.P. & KHAN, O.A. (2000). Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology, 55, 1587-1588.